Daily Stock List
E-Waste Systems, Inc. (EWSI)
First Penny Picks reported recently on E-Waste Systems, Inc. (EWSI), Elite Traders did earlier, and we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
E-Waste Systems, Inc., through subsidiaries, affiliations, licensees, and management contracts, is an electronic waste management and reverse logistics services firm. They formed to create a market-leading, integrated business in the emerging Waste Electrical and Electronic Equipment (WEEE) industry. They target businesses facing regulatory or other mandates for handling e-waste. E-Waste Systems is the first public pure eWaste company.
E-Waste Systems will leverage and extend their acquisitions' established customer relationships through expanding the services offered to customers, applying best practices in professional management, and by investing in modern recycling technology. They base their categories of e-waste on the WEEE Directive categories. The Company has advanced state-of-the-art processes to achieve maximum extraction of materials to produce new manufacturing input.
For E-Waste Recycling, they offer multi-national WEEE-Directive standards of recycling and secure asset recovery and end of life management services. These include management of a client's returns, refurbishment of still useful items, re-use/resale, and complete recycling services. They operate with a zero-landfill objective and provide certificates of data destruction with access to visual evidence of the processing.
E-Waste Systems can handle a broad assortment of products and materials. This includes the complete range of IT and electronic assets. The Company mainly targets circuit board based electronics, including consumer electronics such as cell phones, DVDs, and televisions; IT equipment such as computers, monitors, and hard drives; and high-end communications equipment such as server plants. They will accept equipment from all of the WEEE categories.
Effective January 26, 2013, E-Waste Systems became the indirect holding company of Shanghai YaZhuo Jiudian Guanli, Ltd. (YaZhuo JCP). They are a recycling company located in the People's Republic of China (PRC). YaZhuo JCP holds patents for the recycling of plastics, including electronic waste plastics. They subsequently process these into new materials for the construction industry. Because of this transaction, E-Waste obtained control of the Company and they exercise this control via their Shanghai office. They provide YaZhuo JCP with management services pursuant to a series of agreements.
Earlier this month, E-Waste Systems announced that they entered into a binding agreement to acquire State of California registered e-Waste Collector and mobile computing specialist, Surf Investments Ltd. of Irvine, California. The expectation is that this acquisition will add $1 million in annual revenues. Surf Investments is a registered collector of eWaste in the State of California. They have recognition as a warranty authorized center for repair, returns, and resale by major OEM manufacturers.
Last week, E-Waste Systems announced expansion plans into Australia and the southern hemisphere. The Company signed a binding Memorandum of Understanding (MOU) with 1800eWaste, Ltd., intended to result in deployment of E-Waste's ePlant1000™ technology. 1800eWaste is Australia's foremost electronic waste collection and recycling service provider.
We're keeping an eye on E-Waste Systems, Inc. (EWSI) and tracking them on our radar as "One to Watch" here at the QualityStocks Daily Newsletter.
E-Waste Systems, Inc. (EWSI), closed Thursday's trading session at $0.013, up 8.33%, on 467,272 volume with 19 trades. The average volume for the last 60 days is 714,440 and the stock's 52-week low/high is $0.0026/$0.047.
Westinghouse Solar, Inc. (WEST)
Greenbackers, Penny Stock Rumble, Alternative Energy, Street Insider, OTCPicks, and PennyTrader Publisher reported earlier on Westinghouse Solar, Inc. (WEST), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2001, Westinghouse Solar, Inc. is a designer and manufacturer of integrated rooftop solar power systems. They design and manufacture solar power systems and solar panels with integrated microinverters. They call these AC solar panels. The design of their products is for use in solar power systems for residential and commercial rooftop customers. They introduced their "plug and play" solar panel technology (brand name Andalay), in September 2007. Westinghouse Solar is based in Campbell, California.
Westinghouse Solar broke new ground in 2009 with the first integrated AC solar panel, reducing the number of components for a rooftop solar installation by approximately 80 percent and lowering labor costs by approximately 50 percent. This AC panel won the 2009 Popular Mechanics Breakthrough Award. It has become the industry's most widely installed AC solar panel. In 2012, Westinghouse Solar introduced a new generation of products named "Instant Connect".
Westinghouse Solar has three U.S. patents that cover key aspects of their solar panel technology, and U.S. Trademark No. 3481373 for registration of the mark "Andalay." The Company received three foreign patents in 2010. A Korean Patent was issued in 2007.
The Company has seven issued patents and eighteen other pending U.S. and foreign patent applications that cover the Andalay technology working their way through the USPTO and foreign patent offices. Westinghouse designs, markets and sells their solar power systems to solar installers, trade workers and do-it-yourself customers in the U.S. and Canada via distribution partnerships, the Company's dealer network, and retail outlets.
In addition, the Company has their Westinghouse Solar Authorized Dealer Program. The Westinghouse Solar Dealer Program provides opportunities for installers. They can build their business with a trusted brand name and premier technology from the Company. Their program provides installers with the rights to use the highly recognizable Westinghouse name and logo; Dealer Financing; sales tools such as collateral, presentations and videos to help them close more deals; sales leads, technical and sales training, and more.
In April, Westinghouse Solar announced that they and CBD Energy negotiated a sub-license for use of the Westinghouse Solar brand and technologies in Australia. Westinghouse Solar and CBD Energy are parties to a pending merger agreement. The expectation is that this agreement will be completed in the third quarter of calendar year 2013, subject to shareholder approval of both companies. CBD Energy is a diversified renewable energy company.
Westinghouse Solar, Inc. (WEST), closed Thursday's trading session at $0.033, down 2.94%, on 2,931,360 volume with 123 trades. The average volume for the last 60 days is 1,089,414 and the stock's 52-week low/high is $0.029/$0.20.
Inscor, Inc. Corp. (IOGA)
TryBestPennyStocks, Stockhouse, PennyStockSpy, Greenbackers, PennyStocks24, OTPicks, StockTwiter, Penny Champions, Penny Dreamers, and The Green Baron reported this month on Inscor, Inc. Corp. (IOGA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Inscor, Inc. Corp. specializes in educating and marketing the FIT (Financed Insurance Trust) OPEB (Other Post-Employment Benefits) plan to municipalities and corporations as a low-cost solution to funding retiree and other employee benefits. Inscor is a leading independent insurance national consulting and marketing organization of life, disability-income and long-term care insurance and other financial tools and services in addition to a wide array of products marketed through their financial and insurance professional advisors across the country. Inscor has their headquarters in Las Vegas, Nevada.
A FIT is for protecting lifestyle, income and assets for loved-ones and for securing one's future retirement. With a FIT, the cost of permanent life insurance is financed through major lending institutions. Policy cash values provide collateral; they are later used, in part, to retire the loan including principal and interest. The policyholder's assets remain in place; they need not be used to pay insurance premiums.
The Company's FIT OPEB (Other Post-Employment Benefits) plan is a feasible solution to providing considerable cash flows to fund OPEB liabilities with little, if any, increases in out-of-pocket expenditures.
FIT plans can undergo modeling to provide substantial volumes of life insurance. Additionally, they can be modeled to create substantial cash values that can be accessed to provide a tax-free income stream during retirement.
Inscor, by way of collaboration with insurance companies, financing institutions, actuaries, and attorneys, has developed FIT strategies tailored for specific market segments. Inscor also offers interest rate risk management/risk control instruments, business succession, and executive compensation solutions. In addition, they offer retirement, and financial and estate planning services.
Last week, Inscor announced the addition of Dominique Wilkins to the Company's Board of Directors and appointment as Vice-Chairman. Mr. Wilkins' responsibilities will include acting as spokesman, promoting goodwill and developing the Company's relations with professional athletes and sport associations. His efforts will help facilitate the marketing of Inscor's FIT plan and related financial products and services to professional athletes and other affluent individuals in the industry.
Inscor, Inc. Corp. (IOGA), closed Thursday's trading session at $0.545, up 22.47%, on 69,382 volume with 58 trades. The average volume for the last 60 days is 15,656 and the stock's 52-week low/high is $0.025/$2.00.
Metals Creek Resources Corp. (MEK.V)
Agoracom reported previously on Metals Creek Resources Corp. (MEK.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Metals Creek Resources Corp. is a junior exploration company whose shares trade on the TSX Venture Exchange. The Company has recently formed a 50/50 joint venture (JV) with Goldcorp, to continue exploring the Ogden Gold property. This includes the former Naybob Gold mine, located 6 km south of Timmins, Ontario. Additionally, Metals Creek engages in the identification, acquisition, exploration and development of other mineral resource properties.
Currently, the Company has mining interests in Ontario, Yukon and Newfoundland and Labrador (NL). Concerning the JV, Metals Creek Resources will be the operator and subsequent programs will be funded on a 50/50 basis. This is as both companies contribute their share of required funding in the Ogden Gold Property.
Metals Creek is planning to complete a trenching and drilling program on their Squid East project located within the White Gold district in the Yukon. This program will be funded by GTA Resources and Mining, Inc. GTA can earn up to 70 percent of the project interest over a five-year period.
In the Yukon, Metals Creek acquired, via staking, 166 claim units in four separate blocks in the Dawson Range gold district in 2011. Three of the claim blocks are in the Matson Creek area, nearest to the Matson Creek placer gold camp, and the fourth block is west of the Yukon River, 40 km north of Kinross Gold's White Gold property. The claims were staked to cover several gold geochemical anomalies.
Yesterday, Metals Creek Resources reported assay results from the remaining three holes of their recently completed diamond drill program on the Ogden Gold Project in Timmins, Ontario. The drill program consisted of eight holes targeting the Thomas Ogden Zone (TOZ) designed to test the on-strike and down dip extent of previously defined gold mineralization.
Highlights from these latest holes include hole TOG-13-25, which returned a bonanza grade gold intercept of 2,732.6 grams per tonne (g/t) gold over 0.93 meters (m). This intercept was part of a broader zone of high-grade mineralization with an uncut intercept of 210.19 g/t over 12.53 m. The Ogden claims cover eight kilometers of strike length of the Porcupine-Destor Break between Goldcorp's Dome Mine and Lake Shore Gold's West Timmins Mine.
Metals Creek Resources Corp. (MEK.V), closed Thursday's trading session at $0.05, even for the day, on 168,000 volume. The stock's 52-week low/high is $0.04/$0.08.
Network-1 Security Solutions, Inc. (NSSI)
Real Pennies, Wall Street Corner, FeedBlitz, BullRally, PennyInvest, Stock Rich, StockEgg, Stockpalooza, CoolPennyStocks, and HotOTC reported on Network-1 Security Solutions, Inc. (NSSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Based in New York City, Network-1 Security Solutions, Inc. engages in the acquisition, development, licensing and protection of their intellectual property (IP) and proprietary technologies. Currently, the Company owns 19 patents covering assorted telecommunications and data networking technologies and technologies relating to document stream operating systems and the identification of media content. Additionally, Network-1 looks to acquire additional IP assets and enter into strategic relationships with third parties to monetize their IP assets.
Network-1 identifies and acquires IP from companies, inventors, and implements industry-wide licensing programs on reasonable terms to enable extensive adoption. Therefore, Network-1 can maximize the value of the technologies and generate returns for the inventor's research and development investments. Inventors and firms that sell their IP to the Company may retain a stake in the royalties generated by their licensing efforts. This enables them to protect and monetize their technology without the sizeable expense and effort required to enforce IP rights.
Currently, Network-1 has 16 license agreements with respect to their Remote Power Patent. These include, among others, license agreements with Cisco Systems, Inc., Cisco Linksys, Inc., Extreme Networks, Inc., Netgear, Inc., Motorola Solutions, Inc., Allied Telesis, Inc., NEC Corp. and numerous other data networking vendors. The Remote Power Patent covers the remote delivery of power over Ethernet networks. The U.S. Office of Patents and Trademarks granted the Remote Power Patent on April 21, 2001; it expires on March 11, 2020.
Recently, Network-1 Security Solutions announced financial results for the three months ended March 31, 2013. They had revenue of $4,064,000 for the three months ended March 31, 2013, in comparison to revenue of $4,425,000 for the three months ended March 31, 2012. The decrease of $361,000 or 8 percent in revenue for the three months ended March 31, 2013 was mainly due to greater license initiation fees achieved from patent litigation settlements of $565,000 in the three months ended March 31, 2012, versus $258,000 in the three months ended March 31, 2013. Net of such license initiation fees, royalty revenue for the three months ended March 31, 2013 decreased 1.4 percent to $3,806,000 from $3,860,000.
The Company reported net income of $1,392,000 or $0.06 per share ($.05 per share on a diluted basis) for the three months ended March 31, 2013. This is in comparison to $1,923,000 or $0.08 per share ($.07 per share on a diluted basis) for the three months ended March 31, 2012.
Yesterday, Network-1 announced that their newly formed subsidiary, Mirror Worlds Technologies, LLC, acquired all of the patents previously owned by Mirror Worlds, LLC. The newly acquired Patent Portfolio includes 9 issued United States patents and 5 pending applications covering foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system.
Network-1 Security Solutions, Inc. (NSSI), closed Thursday's trading session at $1.43, up 6.72%, on 126,211 volume with 60 trades. The average volume for the last 60 days is 18,185 and the stock's 52-week low/high is $1.01/$1.59.
WellQuest Medical & Wellness Corp. (WEQL)
Real Pennies, Breaking Stock Reports, and UltimatePennyStock reported earlier on WellQuest Medical & Wellness Corp. (WEQL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
WellQuest Medical & Wellness Corp., together with their subsidiary, WellQuest of Arkansas, Inc., provides an integrated medical delivery site. This consists of family physician healthcare services, preventive/wellness services, as well as medical skin-care services. In addition to treatment, the Company integrates modern medicine with a preventive focus. They previously went by the name HQHealthQuest Medical & Wellness Centers, Ltd. They changed their corporate name to WellQuest Medical & Wellness Corp. in April of 2008. WellQuest has their headquarters in Bentonville, Arkansas. The Company's shares trade on the OTC Pink Current Information.
The Company offers occupational health services for business; preventive health alternatives, including life-style counseling, weight loss and nutritional counseling, fitness counseling, vitamin and supplement therapies, and disease management counseling. They additionally offer aggressive medical aesthetics, such as laser treatments, injections, chemical peels, as well as therapeutic massages.
WellQuest Medical & Wellness is a foremost provider of services including Medical Weight-Loss, Allergy Testing, Occupational Services, and Medically Supervised Anti-Aging treatments. Concerning their WellQuest Medical Center, it is a physician-directed medical service for families and health-conscious businesses. They offer a complete spectrum of medical care for adults and children along with digital diagnostic tests. These include laboratory, x-ray, EKG, and more.
Concerning Wellness, the WellQuest Team works to design personalized treatment plans. Their objective is a partnership between the medical providers and the clients. Pertaining to Anti-Aging, the Company provides their Medical Spa services to treat the skin, and, exclusive to WellQuest in Northwest Arkansas is Skinprint, a company rooted in clinical skin research. Starting with the Biometric Skinprint Unit, the certified Skinprint specialist takes ultraviolet photos revealing underlying oxidation damage, bacterial presence and different pigmentation patterns and their depths.
For Corporate Services, the Company delivers Corporate Wellness in three different phases. These are Analysis, Solutions, and Prevention. Each phase is accompanied by WellQuest's unique availability and intervention-driven business model.
WellQuest Medical & Wellness Corp. (WEQL), closed Thursday's trading session at $0.085, up 183.33%, on 3,934,519 volume with 602 trades. The average volume for the last 60 days is 8,242 and the stock's 52-week low/high is $0.004/$0.099.
Castillian Resources Corp. (CTIIF)
We are reporting on Castillian Resources Corp. (CTIIF), here at the QualityStocks Daily Newsletter.
Castillian Resources Corp. is a mineral exploration company that lists on the OTCQX International. Headquartered in Toronto, Ontario, the Company has gold and base metal properties in Canada and South America. Their flagship property is the Hope Brook Gold Project in southwestern Newfoundland. At the Hope Brook Gold Project, Castillian is carrying out a 25,000-meter diamond drill program.
The Hope Brook Gold Project has 2.4 million tonnes at 1.48 g Au/t for 590,000 ounces of National Instrument (NI) 43-101 compliant indicated mineral resources and 8.2 million tonnes at 2.07 g Au/t for 548,000 ounces of inferred mineral resources. At this Project, the deposit is open along strike and at depth with several target areas already defined. The Company believes there is excellent potential to expand the resource.
The bulk of these aforementioned ounces are within a potentially open pittable constraining shell defined at US$1,400 gold and a cutoff grade of 0.5 g Au/t. The property includes the former Hope Brook mine, which produced 752,163 ounces of gold from 1987 to 1997. The mine also produced a copper concentrate from 1993 to 1997.
In January 2013, Castillian Resources announced that they completed 5,951 meters of reconnaissance diamond drilling in 21 holes at their Hope Brook Gold Project. Highlights include a major new near surface target zone within the Connector Zone and above the 240 Zone that extends along strike for approximately 800m to a depth of more than 300m.
Earlier this month, Castillian Resources and Ridgemont Iron Ore Corp. announced that they signed a definitive arrangement agreement. With this, Castillian will acquire all of the outstanding shares of Ridgemont through a plan of arrangement under the Business Corporations Act (British Columbia). The Board of Directors of each company has unanimously approved the Transaction.
Upon completion of the Transaction, existing Castillian and Ridgemont shareholders will own approximately 57.8 percent and 42.2 percent of the combined company, respectively, on a basic shares outstanding basis. This is assuming the issuance by Castillian Resources of 8,000,000 common shares to Ryan Gold Corp. to repurchase Ryan Gold's 10 percent interest in the Hope Brook gold project.
Castillian Resources Corp. (CTIIF), closed Thursday's trading session at $0.0624, up 1.13%, on 1,000 volume with 1 trade. The average volume for the last 60 days is 49,153 and the stock's 52-week low/high is $0.016/$0.08.
TapImmune, Inc. (TPIV)
Ceocast News reported earlier on TapImmune, Inc. (TPIV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TapImmune, Inc. is a vaccine technologies company whose shares trade on the OTC Markets' OTCQB. The Company specializes in the development of innovative gene based immunotherapeutics and vaccines in the areas of oncology and infectious disease. TapImmune's lead product candidates include vaccines designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system. TapImmune has their corporate headquarters in Seattle, Washington.
Recently, TapImmune commenced treating patients in their first Phase 1 immunotherapy clinical trial targeting HER2/neu in breast cancer at the Mayo clinic. This trial uses patented antigen technologies developed at the Mayo clinic and will follow patients for safety and immune responses as the primary endpoints. The Company has the exclusive Option to license this technology.
Moreover, TapImmune is developing TAP-based prophylactic vaccines commercially suitable for the prevention of infectious diseases and as Biodefense agents. As a vaccine component, the gene based TAP technology has the potential to improve the efficacy of prophylactic and immunotherapeutic vaccines significantly, as it addresses a fundamental mechanism for T cell recognition and response. TAP expression additionally has the unique ability to enhance the effector function of mature killer T cells. This enhancement of effector function is potentially complementary to any/all vaccine approaches that are designed to enhance cellular responses.
This month, the Company entered into a Material Transfer Agreement with the Fred Hutchinson Cancer Research Center (FHCRC) in Seattle. The initial objective of this collaboration is to determine levels of TAP1/TAP2 in tissues taken from melanoma patients in a clinical trial at FHCRC using adoptive T-cell therapy and to correlate these levels with clinical outcomes.
TapImmune's intention, with the required funding in place, is to focus their resources on the progression of products in their lead oncology indication, HER2/neu positive breast cancer. The Company will support and expand on their key infectious disease collaborations. This includes their collaboration efforts with the Mayo Clinic and others using grants. TapImmune has applied for a grant in collaboration with the Mayo Clinic to progress their smallpox program and extend it to additional emerging viral threats.
TapImmune, Inc. (TPIV), closed Thursday's trading session at $0.06, up 23.20%, on 1,768,111 volume with 103 trades. The average volume for the last 60 days is 65,319 and the stock's 52-week low/high is $0.03/$0.16.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.2598, up 4.63%, on 396,017 volume with 52 trades. The stock’s average daily volume over the past 60 days is 136,725, and its 52-week low/high is $0.2483/$1.25.
The Aristocrat Group Corp. proudly unveiled their debut product today, an American-made and gluten-free ultra premium vodka destined to rock the burgeoning $21.3B domestic distilled spirits market, RWB Ultra-Premium Handcrafted Vodka. This fine, handcrafted vodka, made from 100% Idaho potatoes by the state's famous master distillers, Distilled Resources, Inc., has been prepped to explode on the scene by diligent market cultivation in key markets like Las Vegas by ASCC management and the company's brand management division, Luxuria Brands.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Unveils Debut Spirits Brand RWB Vodka
ASCC Forecasts Big Growth This Summer
ASCC’s New Vodka Expected to Meet Federal Requirements for ‘Gluten-Free’ Labeling
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.043, off by 3.37%, on 4,859,479 volume with 128 trades. The stock’s average daily volume over the past 60 days is 2,078,484, and its 52-week low/high is $0.0275/$0.155.
Advaxis Inc. was excited to report filing a key proxy statement supplement today with the SEC (Form DEFR14A), revising proposals to the April 30 proxy statement, including a high-end limitation on the reverse stock split to 1-for-125, a decrease in the total number of authorized shares of common stock post-split to 50M, and the amendment to the 2011 Omnibus Incentive Plan limiting the requested increase amount to 75M shares of common stock. In light of these changes, the ADXS Board of Directors has also given stockholders more time to go over the proposals, moving the Annual Meeting of Stockholders of Advaxis, Inc. to June 14, 2013, at 10:00 a.m., Eastern Daylight Time, at the Princeton Marriott, 100 College Road East, Princeton, New Jersey 08540.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
Advaxis Announces 2013 Annual Meeting of Stockholders
Advaxis Announces Promotion of Dr. Robert Petit and Daniel J. O’Connor
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.07, off by 6.67%, on 250,196 volume with 31 trades. The stock’s average daily volume over the past 60 days is 158,821 and its 52-week low/high is $0.0322/$3.63.
DoMark International, Inc. reported today that they have completed the 29% equity capital acquisition of a private product developer of a mobile accessory for use with the major smartphone manufacturers. CEO of DOMK, Andy Ritchie, was pleased to report that details about this product would emerge as the launch date approaches for global and domestic U.S. markets, hinting that the product would be of huge value to multimedia and gaming interests on the mobile platforms keen to enhance user experience when gaming or watching TV on the device.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
Investment in Game Changing New Multi-Media Games Product Developer Imagic Ltd by Smartphone Accessory Supplier DoMark International
DoMark International Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares
DoMark Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.029, up 16.00%, on 329,174 volume with 6 trades. The stock’s average daily volume over the past 60 days is 394,190, and its 52-week low/high is $0.001/$0.12.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Enters Partnership Agreement With KO Entertainment, Inc.
Consorteum Holdings Reaches Strategic Partnership Agreement With Knockout Gaming
Consorteum Holdings Inc. Reaches Funding Agreement With Private Equity Group
Following months of careful preparation, today the Aristocrat Group Corp. proudly unveiled its debut product for the $21.3 billion domestic distilled spirits market: RWB Ultra-Premium Handcrafted Vodka, a gluten-free liquor made in the U.S.A. To view the spirit’s bottle design, visit http://luxuriabrands.com/products.
ASCC was given final federal approval on the RWB Vodka name and label from the Alcohol and Tobacco Tax and Trade Bureau (TTB) last week. This new vodka will be one of only a handful of spirits in the U.S. that meets the necessary requirements to feature the words “gluten-free” on its label and packaging, potentially giving the company a major advantage as the gluten-free market place continues to grow rapidly.
ASCC and its brand management division, Luxuria Brands, have worked closely with Idaho distiller Distilled Resources, Inc. to produce a beverage with the highest odds of success in the booming, $5.5 billion U.S. vodka market. Distilled from Idaho russet potatoes, RWB Vodka will stand out on the shelf, take pride in its American roots, fit neatly within established pricing hierarchy, and appeal to a wide market of vodka lovers. Ignite Advertising was tapped to create unique packaging designs and concepts for the new product.
The company said it will be releasing more details on RWB Vodka’s exact release date as soon as they’re available; however, the ultra-premium spirit is scheduled to hit the market this summer. ASCC is currently in talks with clubs and venues in Las Vegas and Los Angeles about hosting official premiere events promoting the release of its debut vodka product.
For more information on the Aristocrat Group, visit www.aristocratgroupcorp.com
Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the filing of a Form DEFR14A, proxy statement supplement, with the U.S. Securities and Exchange Commission. The action revises certain proposals in the proxy statement originally filed on April 30, 2013.
Advaxis has made the following changes:
• Proposal No. 2: the proposal to approve a reverse stock split, to now limit the high end of the range proposed to 1-for-125 (in the earlier proxy, we proposed a range of 1-for-70 to 1-for-200);
• Proposal No. 3: the proposal to decrease the total number of authorized shares of common stock, to now decrease the total number of authorized shares of common stock post-reverse stock split to 50,000,000 shares (in the earlier proxy, we proposed a total number of 300,000,000 shares of common stock post-reverse stock split); and
• Proposal No. 4: the proposal to approve an amendment to our 2011 Omnibus Incentive Plan, to now limit the amount of the requested increase to 75,000,000 shares of common stock (in the earlier proxy, we proposed an increase of 155,000,000 shares of common stock).
In an effort to give stockholders more time to consider the revised proposals, Advaxis’ Board of Directors has resolved to postpone the meeting. This year’s Annual Meeting of Stockholders will be held on a new date, June 14, 2013, at 10:00 a.m., Eastern Daylight Time, at the Princeton Marriott, 100 College Road East, Princeton, New Jersey 08540.
The proxy statement supplement is being mailed to stockholders of record as of the close of business on April 15, 2013.
For more information, visit www.advaxis.com
Today before the opening bell, DoMark International, a mobile accessory supplier, announced the acquisition of 29% of the equity capital of Imagic Ltd.
Imagic, a private company, has developed a mobile accessory product for use with major smartphone manufacturers. DoMark will share a more detailed description of the product nearer to its launch date later this year in the USA and global markets. This investment was made in a combination of cash and shares totaling a value of $580,000.
DoMark CEO, Andy Ritchie stated, “This is a uniquely innovative product which we believe to have a huge potential appeal to multi-media games players, and improves the user experience while playing games on mobiles and on TV. Mobile content revenues are due to rise from $40 Billion this year to $65 Billion in 2016 of which games form the greater part. This product adheres to DoMark’s investment criteria, in that it is patent pending, mass market, and game changing with excellent sales margins.”
Mr. John Bentley, who has recently joined the Board of Imagic as a director, has accepted an invitation to join the DoMark Board in due course to assist in the liaison between DoMark and Imagic nearer to the time of the launch of the Imagic product. Previously the Chairman of the UK’s largest toy company, Bentley would join DoMark with extensive experience worldwide in media, movies, video, and digital games in listed UK companies he has directed. He was the original creator and instigator of Internet on TV which he developed and launched in the USA nearly two decades ago through a privately held company, Viewcall America, whose business was later sold to a subsidiary of Oracle Corporation Inc.
For more information on DoMark International, visit www.domarkintl.com
International Stem Cell’s recent Q1 financial release emphasizes the critical contribution of the company’s two subsidiaries, Lifeline Cell Technologies and Lifeline Skin Care, in supporting the continued development and application of parthenogenetic stem cell technology. The company has made considerable progress, demonstrating to the scientific community how neuronal cells based on their proprietary stem cell platform can be used to treat Parkinson’s disease. It’s important progress that is being financially backed by healthy subsidiary generated revenue, with sales growth and efficiencies that reflect ongoing marketing and operational improvements.
Lifeline Skin Care technology is based on discoveries made by ISCO research scientists working on cures for diabetes and Parkinson’s disease. Their skin care creams are unlike any other, and represent the only products in the world that use human, non-embryonic stem cell extracts. By combining the latest in stem cell biology and nanotechnology, the company has created the highest quality, scientifically tested, most effective anti-aging skin care formulations available anywhere. It represents a compelling market presence that continues to grow revenue, which in turn allows ISCO’s life-saving research to move forward.
Lifeline Cell Technology has long been accepted in the marketplace as the place to go for all types of purified primary human cells and reagents. Offering an extensive list of cell and tissue types, along with cell culture media and other products, the company has become an industry leader, known for its meticulous quality testing, constant innovation, and a passion for customer and technical care. Lifeline Cell Technology has actually developed many of the human cell systems and quality standards used today in academic, government, and pharmaceutical laboratories to study human disease, with the company’s strong reputation fueling impressive revenue growth that supports much of ISCO’s work.
For additional information, visit www.InternationalStemCell.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Smartphone Accessory Supplier, Makes Major Investment in Promising New Multi-Media Games Product Developer Imagic Ltd
- GNCC Capital, Inc. (GNCP) Reaches Agreement to Acquire White Hills Gold Properties
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- International Stem Cell Corp. (ISCO) to Present at Two Upcoming Investor Conferences
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
- Solar Wind Energy Tower, Inc. (SWET) Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"
- The Aristocrat Group Corp. (ASCC) Unveils Debut Spirits Brand RWB Vodka
- The Guitammer Company Inc. (GTMM) Teams Up With Warner Bros. and Legendary Picturesfor Summer Release of "Pacific Rim," From Oscar® Nominated Director, Guillermo del Toro
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Private Placements
- Viaspace, Inc. (VSPC) and AGRICORP Sign Joint Development Agreement for 12 MW Power Plant Co-located with 2,100 acre Giant King Grass Plantation in Nicaragua
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue